<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="336797">
  <stage>Registered</stage>
  <submitdate>12/04/2011</submitdate>
  <approvaldate>12/04/2011</approvaldate>
  <actrnumber>ACTRN12611000379910</actrnumber>
  <trial_identification>
    <studytitle>Betadine Trial -Does use of Betadine solution to wound prior to closure of skin at caesarean section affect wound healing and or infection after caesarean section</studytitle>
    <scientifictitle>Does use of Betadine solution to wound prior to closure of skin at caesarean section affect wound healing and or infection after caesarean section</scientifictitle>
    <utrn />
    <trialacronym>Nil</trialacronym>
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Post caesarean section wound healing and sepsis</healthcondition>
    <conditioncode>
      <conditioncode1>Infection</conditioncode1>
      <conditioncode2>Studies of infection and infectious agents</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Surgery</conditioncode1>
      <conditioncode2>Surgical techniques</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Childbirth and postnatal care</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>prior to closure of skin at caesarean section women will be randomised to betadine or no betadine soak of the wound.
20 mls of betadine solution is poured onto the incision site prior to skin closure and skin closed as normal practice within 30 seconds.</interventions>
    <comparator>No betadine</comparator>
    <control>Active</control>
    <interventioncode>Prevention</interventioncode>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Wound infection within 6 weeks of delivery - this will be by phone contact and or a letter - currently this is the routine practice by the infection control unit for all c/sections.
Chart audit if admitted to hospital</outcome>
      <timepoint>6 weeks post partum</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Wound healing -phone interview or lettter and chart audit if admitted to hospital</outcome>
      <timepoint>6 weeks</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>all women having caesarean section</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>No limit</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>nil</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>stratified by elective c/section or c/section in labour
consecutively numbered opaque envelopes containing the allocation will be in theatre and will only be opened immediately prior to skin closure</concealment>
    <sequence>random number table with block of 10</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures>nil</designfeatures>
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>1/11/2009</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>3000</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Kassam mahomed</primarysponsorname>
    <primarysponsoraddress>Dept of obstetrics
chelmsford Avenue
Ipswich Hospital Ipswich qld 4305</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname />
      <fundingaddress />
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname>kassam mahomed</fundingname>
      <fundingaddress>Dept of obstetrics
chelsford Avenue
Ipswich Qld 4305</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Infection after c/section is a concern for women and health workers. Prophylactic antibiotics are used to prevent infection but some will still develop the complication. betadine is routinely used for skin preparation prior to c/section. It is believed that its use again immediately prior to skin closure may further reduce the infection rate.
This is an open randomsied controlled trial. Hospital infection control dept routinely make contact with all c/section women. This source will be used to gather information on women who develop any problem with ht ewound. They routinely provide consent to be contacted for this purpose and therefore no additional consent will be required .</summary>
    <trialwebsite>nil</trialwebsite>
    <publication>nil yet</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Darling Downs and West Morton health Service district DWMHSD HREC</ethicname>
      <ethicaddress>The Park - centre for mental health
Ellerton Road
Wacol
Qld 4074</ethicaddress>
      <ethicapprovaldate>15/10/2009</ethicapprovaldate>
      <hrec>47-09</hrec>
      <ethicsubmitdate>12/08/2009</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>A/Professor Kassam Mahomed</name>
      <address>chelmsford Avenue
Dept of Obstetrics
Ipswich Hospital Ipswich qld 4305</address>
      <phone>+61 407034283</phone>
      <fax>+61 7 38101598</fax>
      <email>kassam_mahomed@health.qld.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>A/Professor Kassam Mahomed</name>
      <address>Chelmsford Avenue
Dept of Obstetrics
Ipswich Hospital Ipswich qld 4305</address>
      <phone>+61 407034283</phone>
      <fax>+61 7 38101598</fax>
      <email>kassam_mahomed@health.qld.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>A/Professor Kassam Mahomed</name>
      <address>chelmsford avenue
Dept of Obstetrics
Ipswich Hospital Ipswich qld 4305</address>
      <phone>+61 407034283</phone>
      <fax>+61 7 38101598</fax>
      <email>kassam_mahomed@health.qld.gov.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>